These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. McAlister VC; Haddad E; Renouf E; Malthaner RA; Kjaer MS; Gluud LL Am J Transplant; 2006 Jul; 6(7):1578-85. PubMed ID: 16827858 [TBL] [Abstract][Full Text] [Related]
8. Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients. Penninga L; Wettergren A; Wilson CH; Chan AW; Steinbrüchel DA; Gluud C Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD010253. PubMed ID: 24901467 [TBL] [Abstract][Full Text] [Related]
9. Antibody induction versus corticosteroid induction for liver transplant recipients. Penninga L; Wettergren A; Wilson CH; Chan AW; Steinbrüchel DA; Gluud C Cochrane Database Syst Rev; 2014 May; 2014(5):CD010252. PubMed ID: 24880007 [TBL] [Abstract][Full Text] [Related]
10. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients. Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102 [TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients. Penninga L; Wettergren A; Chan AW; Steinbrüchel DA; Gluud C Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD008852. PubMed ID: 22419339 [TBL] [Abstract][Full Text] [Related]
13. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients. Hong T; Zhang M; Fan J Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009698. PubMed ID: 26457607 [TBL] [Abstract][Full Text] [Related]
14. Bile acids for liver-transplanted patients. Poropat G; Giljaca V; Stimac D; Gluud C Cochrane Database Syst Rev; 2010 Mar; (3):CD005442. PubMed ID: 20238339 [TBL] [Abstract][Full Text] [Related]
15. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. Webster AC; Woodroffe RC; Taylor RS; Chapman JR; Craig JC BMJ; 2005 Oct; 331(7520):810. PubMed ID: 16157605 [TBL] [Abstract][Full Text] [Related]
16. Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis. Rodríguez-Perálvarez M; Guerrero-Misas M; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011639. PubMed ID: 28362060 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis. Lan X; Liu MG; Chen HX; Liu HM; Zeng W; Wei D; Chen P World J Gastroenterol; 2014 Sep; 20(34):12330-40. PubMed ID: 25232269 [TBL] [Abstract][Full Text] [Related]
18. Tacrolimus-based versus cyclosporine-based immunosuppression in hepatitis C virus-infected patients after liver transplantation: a meta-analysis and systematic review. Liu Z; Chen Y; Tao R; Xv J; Meng J; Yong X PLoS One; 2014; 9(9):e107057. PubMed ID: 25198195 [TBL] [Abstract][Full Text] [Related]
19. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients. Montero N; Webster AC; Royuela A; Zamora J; Crespo Barrio M; Pascual J Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD007669. PubMed ID: 25220222 [TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A for primary biliary cirrhosis. Gong Y; Christensen E; Gluud C Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD005526. PubMed ID: 17636804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]